Renal injury is reported to have a high mortality rate. Additionally, there are several limitations to current conventional treatments that are used to manage it. This study evaluated the protective effect of hesperidin against ischemia/reperfusion (I/R)-induced kidney injury in rats. Renal injury was induced by generating I/R in kidney tissues. Rats were then treated with hesperidin at a dose of 10 or 20 mg/kg intravenously 1 day after surgery for a period of 14 days. The effect of hesperidin on renal function, serum mediators of inflammation, and levels of oxidative stress in renal tissues were observed in rat kidney tissues after I/R-induced kidney injury. Moreover, protein expression and mRNA expression in kidney tissues were determined using Western blotting and RT-PCR. Hematoxylin and eosin (H&E) staining was done for histopathological observation of kidney tissues. The data suggest that the levels of blood urea nitrogen (BUN) and creatinine in the serum of hesperidin-treated rats were lower than in the I/R group. Treatment with hesperidin also ameliorated the altered level of inflammatory mediators and oxidative stress in I/R-induced renal-injured rats. The expression of p-IκBα, caspase-3, NF-κB p65, Toll-like receptor 4 (TLR-4) protein, TLR-4 mRNA, and inducible nitric oxide synthase (iNOS) was significantly reduced in the renal tissues of hesperidin-treated rats. Histopathological findings also revealed that treatment with hesperidin attenuated the renal injury in I/R kidney-injured rats. In conclusion, our results suggest that hesperidin protects against renal injury induced by I/R by involving TLR-4/NF-κB/iNOS signaling.
Abuelsaad AS, Mohamed I, Allam G, Al-Solumani AA. Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model. Life Sci 2013; 93(20): 714–22, https://doi.org/10.1016/j.lfs.2013.09.019.
Arsenijevic J, Pavlova M, Rechel B, Groot W. Catastrophic health care expenditure among older people with chronic diseases in 15 European countries. PLoS One 2016; 11(7): e0157765, https://doi.org/10.1371/journal.pone.0157765.
Case J, Khan S, Khalid R, Khan A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013; 2013: 479730, https://doi.org/10.1155/2013/479730.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2017; 9(6): 7204–18, https://doi.org/10.18632/oncotarget.23208.
Chenxu G, Minxuan X, Yuting Q, Tingting G, Jinxiao L, Mingxing W, et al. iRhom2 loss alleviates renal injury in long-term PM2.5-exposed mice by suppression of inflammation and oxidative stress. Redox Biol 2018; 19: 147–57, https://doi.org/10.1016/j.redox.2018.08.009.
Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease. Nutrients 2017; 9(7): 718, https://doi.org/10.3390/nu9070718.
Du T, Zhu YJ. The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells. Mediators Inflamm 2014; 2014: 261697, https://doi.org/10.1155/2014/261697.
Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74(1): 101–7, https://doi.org/10.1038/ki.2008.107.
Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J 2013; 2013: 162750, https://doi.org/10.1155/2013/162750.
Lee K-A, Lee S-H, Lee Y-J, Baeg SM, Shim J-H. Hesperidin induces apoptosis by inhibiting Sp1 and its regulatory protein in MSTO-211H cells. Biomol Ther (Seoul) 2012; 20(3): 273–9, https://doi.org/10.4062/biomolther.2012.20.3.273.
Li M, Guo Z, Shao H, Qin B. Therapeutic effect of hesperidin on severe acute pancreatitis in rats and its mechanism. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2017; 29(10): 921–5, https://doi.org/10.3760/cma.j.issn.2095-4352.2017.10.012.
Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev 2015; 4(2): 20–7, https://doi.org/10.12861/jrip.2015.06.
Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev 2017; 2017: 6501046, https://doi.org/10.1155/2017/6501046.
Milenkovic D, Deval C, Dubray C, Mazur A, Morand C. Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLoS One 2011; 6(11): e26669, https://doi.org/10.1371/journal.pone.0026669.
Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014; 20(7): 1126–67, https://doi.org/10.1089/ars.2012.5149.
Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res 2015; 29(3): 323–31, https://doi.org/10.1002/ptr.5256.
Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007; 9(1): 49–89, https://doi.org/10.1089/ars.2007.9.49.
Sherif IO, Al-Shaalan NH. Vildagliptin attenuates hepatic ischemia/reperfusion injury via the TLR4/NF-κB signaling pathway. Oxid Med Cell Longev 2018; 2018: 3509091, https://doi.org/10.1155/2018/3509091.
Tripathi AS, Mazumder PM, Chandewar AV. Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in STZ-induced diabetic rats. J Basic Clin Physiol Pharmacol 2016; 27(1): 57–62, https://doi.org/10.1515/jbcpp-2015-0035.
Vaidya VS, Ferguson MA, Bonventre JV: Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 2008; 48: 463–93, https://doi.org/10.1146/annurev.pharmtox.48.113006.094615.
Xia R, Sheng X, Xu X, Yu C, Lu H. Hesperidin induces apoptosis and G0/G1 arrest in human non-small cell lung cancer A549 cells. Int J Mol Med 2018; 41(1): 464–72, https://doi.org/10.3892/ijmm.2017.3250.
Yamamoto M, Jokura H, Hashizume K, Ominami H, Shibuya Y, Suzuki A, et al. Hesperidin metabolite hesperetin-7-O-glucuronide, but not hesperetin-3'-O-glucuronide, exerts hypotensive, vasodilatory, and anti-inflammatory activities. Food Funct 2013; 4(9): 1346–51, https://doi.org/10.1039/c3fo60030k.
Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 2008; 19(5): 923–32, https://doi.org/10.1681/ASN.2007090982.
László ROSIVALL (Semmelweis University, Budapest, Hungary)
Anna BERHIDI (Semmelweis University, Budapest, Hungary)
Hungarian Editorial Board
International Editorial Board
Faculty of Medicine, Institute of Translational Medicine
Nagyvárad tér 4, H-1089 Budapest, Hungary
Indexing and Abstracting Services:
|Web of Science|
|Journal Impact Factor||1,697|
|Rank by Impact Factor||
Journal Self Cites
|Journal Citation Indicator||0,47|
|Rank by Journal Citation Indicator||
|Scimago Quartile Score||Medicine (miscellaneous) (Q3)
Physiology (medical) (Q3)
CIte Score Rank
|Physiology (medical) 69/101 (Q3)|
|Rank by||Physiology 62/81 (Q4)|
|Journal Self Cites|
|Rank by Journal||Physiology 67/84 (Q4)|
|Scimago||Physiology (medical) Q3|
|Scopus||Physiology (medical) 71/98 (Q3)|
|Scite Score Rank|
Journal Self Cites
Scite Score Rank
|Physiology (medical) 73/99 (Q3)|
|Article Processing Charge||1100 EUR/article|
|Printed Color Illustrations||40 EUR (or 10 000 HUF) + VAT / piece|
|Regional discounts on country of the funding agency||World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
|Further Discounts||Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
|Subscription fee 2023||Online subsscription: 664 EUR / 806 USD
Print + online subscription: 776 EUR / 942 USD
|Subscription Information||Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.|
|Purchase per Title||Individual articles are sold on the displayed price.|
|Founder||Magyar Tudományos Akadémia|
|H-1051 Budapest, Hungary, Széchenyi István tér 9.|
|H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.|
|Chief Executive Officer, Akadémiai Kiadó|
|Abstract Views||Full Text Views||PDF Downloads|